Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company provides medical services. Georgia-Israel joint clinic founded on 28 October 2008; operates as a limited liability company.
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross Margin | 80.9% | 77.6% | 80.1% | 83.6% | 82.1% | 83.3% | 86.7% | 89.5% |
| EBITDA Margin | 13.3% | 9.9% | 14.6% | -1.6% | -0.7% | 2.0% | 4.6% | 12.5% |
| EBITDAR | 252 | 189 | 406 | 80 | 147 | 204 | 226 | 239 |
| EBITDAR Margin | 13.3% | 9.9% | 18.7% | 4.6% | 8.1% | 9.8% | 12.1% | 21.0% |
| EBIT Margin | 5.1% | 2.6% | 9.0% | -8.1% | -6.7% | -3.2% | -1.4% | 3.1% |
| Net Profit Margin | 1.6% | -4.4% | 9.3% | -5.9% | -0.9% | 2.3% | 5.2% | 12.2% |
| Operating Expense % of Sales | 67.7% | 67.7% | 65.5% | 85.2% | 82.7% | 81.3% | 82.0% | 77.0% |
| Returns | ||||||||
| Return on Assets (ROA) | 2.0% | -6.9% | 13.6% | -7.8% | -1.3% | 3.6% | 8.2% | 11.5% |
| Return on Equity (ROE) | 3.6% | -11.3% | 21.6% | -12.6% | -2.1% | 5.9% | 10.9% | 14.4% |
| ROIC [EBIT / Invested Capital] | 11.4% | 8.1% | 23.3% | -19.7% | -17.9% | -8.8% | -3.7% | 4.5% |
| Leverage & debt balances | ||||||||
| Debt-to-Assets | 7.5% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.13x | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.44x | 0.06x | 0.00x | N/A | N/A | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 56.5% | 61.2% | 63.1% | 61.8% | 59.0% | 62.0% | 75.3% | 80.0% |
| Net Debt | 23 | -121 | -97 | -100 | -86 | -53 | -171 | -170 |
| Cash & Equivalents | 88 | 132 | 97 | 100 | 86 | 53 | 171 | 170 |
| Total Debt | 111 | 12 | N/A | N/A | N/A | N/A | N/A | N/A |
| Liquidity & working capital | ||||||||
| Current Ratio | 1.49x | 1.29x | 1.37x | 1.12x | 1.09x | 1.18x | 1.68x | 1.96x |
| Quick Ratio | 1.49x | 1.29x | 1.26x | 0.98x | 1.09x | 1.18x | 1.68x | 1.96x |
| Cash Ratio | 0.21x | 0.29x | 0.18x | 0.20x | 0.16x | 0.11x | 0.59x | 0.71x |
| Total Current Assets | 633 | 592 | 754 | 560 | 580 | 578 | 488 | 474 |
| Total Current Liabilities | 425 | 457 | 549 | 499 | 532 | 489 | 290 | 241 |
| Inventory | N/A | N/A | 61 | 70 | N/A | N/A | N/A | N/A |
| Trade Receivables | 539 | 395 | 591 | 382 | 417 | 453 | 283 | 272 |
| Trade Payables | 365 | 369 | 432 | 400 | 420 | 385 | 249 | 191 |
| Net Working Capital | 209 | 135 | 205 | 62 | 49 | 89 | 198 | 232 |
| Net Working Capital % of Revenue | 11.0% | 7.1% | 9.4% | 3.6% | 2.7% | 4.3% | 10.6% | 20.4% |
| Trade Working Capital | 173 | 26 | 220 | 52 | -2 | 68 | 34 | 81 |
| Trade Working Capital % of Revenue | 9.1% | 1.4% | 10.1% | 3.0% | -0.1% | 3.2% | 1.8% | 7.1% |
| Change in Trade Working Capital | N/A | -147 | 193 | -168 | -54 | 70 | -34 | 47 |
| Turnover & efficiency | ||||||||
| Inventory Turnover | N/A | N/A | 7.13x | 4.05x | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | 51.2 | 90.2 | N/A | N/A | N/A | N/A |
| Receivables Turnover | 3.53x | 4.83x | 3.67x | 4.51x | 4.35x | 4.60x | 6.62x | 4.19x |
| Days Sales Outstanding (DSO) | 103.5 | 75.6 | 99.3 | 81.0 | 83.8 | 79.4 | 55.2 | 87.2 |
| Payables Turnover | 0.99x | 1.16x | 1.00x | 0.71x | 0.78x | 0.90x | 1.00x | 0.63x |
| Days Payable Outstanding (DPO) | 368.6 | 315.4 | 364.8 | 516.8 | 469.9 | 403.7 | 364.4 | 582.1 |
| Cash Conversion Cycle | -265.1 days | -239.7 days | -214.2 days | -345.6 days | -386.1 days | -324.4 days | -309.3 days | -494.9 days |
| Asset Turnover | 1.29x | 1.58x | 1.46x | 1.32x | 1.40x | 1.62x | 1.59x | 0.95x |
| Cash flow & dividends | ||||||||
| Operating Cash Flow | 89 | 145 | 214 | 156 | 101 | 80 | 220 | 212 |
| Free Cash Flow (OCF − Capex proxy) | 89 | 145 | -23 | 32 | 13 | -22 | 130 | 58 |
| Cash Conversion (OCF / EBITDA) | 35.5% | 76.6% | 67.5% | N/A | N/A | 192.7% | 253.3% | 149.8% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →